My watch list
my.bionity.com  

my.bionity.com

With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.

  • My watch list
  • My saved searches
  • My saved topics
  • My newsletter
Register free of charge
Login  
eng  
DeutschEnglishFrançaisEspañol

Merck KGaA v. Integra Lifesciences I, Ltd.



Merck v. Integra
Supreme Court of the United States
Argued April 20, 2005
Decided June 13, 2005
Full case name: Merck KGaA, Petitioner v. Integra Lifesciences I, Ltd., et al.
Citations:545 U.S. 193; 125 S. Ct. 2372; 162 L. Ed. 2d 160; 2005 U.S. LEXIS 4840; 73 U.S.L.W. 4468; 74 U.S.P.Q.2D (BNA) 1801; 18 Fla. L. Weekly Fed. S 394
Prior history:On writ of cert. to the United States Court of Appeals for the Federal Circuit. Integra Lifesciences I, Ltd. v. Merck KGaA, 331 F.3d 860, 2003 U.S. App. LEXIS 11335 (Fed. Cir., 2003)
Subsequent history: On remand at Integra Lifesciences I, LTD. v. Merck KGaA, 2005 U.S. App. LEXIS 17342 (Fed. Cir., Aug. 17, 2005)
Holding
The Court held that the use of patented compounds in preclinical studies is protected under §271(e)(1) at least as long as there is a reasonable basis to believe that the compound tested could be the subject of an FDA submission and the experiments will produce the types of information relevant to an IND or NDA.
Court membership
Chief Justice: William Rehnquist
Associate Justices: John Paul Stevens, Sandra Day O'Connor, Antonin Scalia, Anthony Kennedy, David Souter, Clarence Thomas, Ruth Bader Ginsburg, Stephen Breyer
Case opinions
Majority by: Scalia
Joined by: unanimous
Laws applied
U.S. Const.; 35 U.S.C. § 271(e)(1)

Merck KGaA, Petitioner v. Integra Lifesciences I, Ltd., et al., 545 U.S. 193 (2005), is a United States Supreme Court case with ramifications for patent law. The dispute dates to approximately 1996 and centers on a federal law known as the "FDA safe harbor".

See also

  • List of United States Supreme Court cases, volume 545
  • United States patent law

References

  • Complete text of the decision
  • Kintisch, E. (2005, April 8). Case probes what's fair game in the search for new drugs. In Science, 308, 174.
  • Mamudi, Sam, Supreme Court broadens research exemption, Managing Intellectual Property, June 14, 2005


 
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Merck_KGaA_v._Integra_Lifesciences_I,_Ltd.". A list of authors is available in Wikipedia.
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE